Oxerutin

Products Venoruton Effects Oxerutin increases the resistance of capillary walls and promotes normalization of their permeability Indications Chronic venous insufficiency Postphlebitic syndrome Trophic disorders Varicose dermatitis Adjuvant after sclerosing treatment and exheresis of varicose veins and in leg ulcers. Symptoms of hemorrhoids Dosage According to the package insert. Contraindications Hypersensitivity First trimester of pregnancy Children … Oxerutin

Azaperone

Products Azaperone is commercially available as a solution for injection (Stresnil). It has been approved in many countries since 1970. Structure and properties Azaperone (C19H22FN3O, Mr = 327.4 g/mol), like haloperidol (haldol), belongs to the butyrphenones. It is a white powder that is practically insoluble in water. Effects Azaperone (ATCvet QN05AD90) is depressant and effective … Azaperone

Azathioprine (Imuran)

Products Azathioprine is commercially available as film-coated tablets and as a lyophilizate (Imurek, generic). It has been approved in many countries since 1965. Structure and properties Azathioprine (C9H7N7O2S, Mr = 277.3 g/mol) is a nitromidazole derivative of mercaptopurine. It exists as a pale yellow powder that is practically insoluble in water. Effects Azathioprine (ATC L04AX01) … Azathioprine (Imuran)

Azelaic Acid for Skin Problems

Products Azelaic acid is commercially available as gel and cream (Skinoren). It has been approved in many countries since 1990. Structure and properties Azelaic acid (C9H16O4, Mr = 188.2 g/mol) is a saturated dicarboxylic acid. It exists as a white, odorless, crystalline solid that is poorly soluble in water at 20°C but dissolves well in … Azelaic Acid for Skin Problems

Azelastine

Products Azelastine is available as a nasal spray and in eye drop form (eg, Allergodil, Dymista + fluticasone, generics). It has been approved in many countries since 1994. Structure and properties Azelastine (C22H24ClN3O, Mr = 381.9 g/mol) is present in drugs as azelastine hydrochloride, a white to almost white crystalline powder. It is a phthalazinone … Azelastine

Azilsartan

Products Azilsartan has been approved in the United States and the EU in tablet form since 2011 (Edarbi). In many countries, it was registered in August 2012 as the 8th member of the sartan drug group. In 2014, a fixed combination with chlortalidone was approved (Edarbyclor). Structure Azilsartan (C25H20N4O5, Mr = 456.5 g/mol) is present … Azilsartan

Azithromycin

Products Azithromycin is commercially available in the form of film-coated tablets, powder for preparation of a suspension, and granules (Zithromax, generic). Furthermore, a granule for the preparation of a sustained-release oral suspension is available (Zithromax Uno). Eye drops have also been released in some countries. Azithromycin has been approved in many countries since 1992. Structure … Azithromycin

Erdostein

Products Erdostein is commercially available in the form of capsules (Mucofor). It was developed at Edmond Pharma in Milan, Italy, and has been approved in many countries since 1994. Structure and properties Erdostein (C8H11NO4S2, Mr = 249.3 g/mol) is a prodrug. The effects are mediated by the free sulfhydryl groups (-SH) of the metabolites. The … Erdostein

Erenumab

Products Erenumab was approved in many countries, in the EU, and in the United States in 2018 as a solution for injection in a prefilled pen and a prefilled syringe (Aimovig, Novartis / Amgen). Structure and properties Erenumab is a human IgG2 monoclonal antibody directed against the CGRP receptor. It has a molecular weight of … Erenumab

Ergocalciferol (Vitamin D2)

Products Ergocalciferol (vitamin D2, calciferol) is commercially available in many countries, including as a dietary supplement in the form of capsules. Vitamin D2 is much less commonly used than cholecalciferol (vitamin D3) in many countries. In the United States, on the other hand, ergocalciferol is more traditionally used. Structure and properties Ergocalciferol (C28H44O, Mr = … Ergocalciferol (Vitamin D2)

Ergotamine

Products In many countries, drugs containing ergotamine are currently no longer on the market. The active ingredient was available in tablet form in combination with caffeine, among other products (Cafergot), but was withdrawn from the market in 2014. Products containing ergotamine were first launched in the 1920s (Gynergen). Structure and properties Ergotamine (C33H35N5O5, Mr = … Ergotamine

Eribulin

Products Eribulin is commercially available as a solution for injection (Halaven). It was approved in many countries and in the EU in 2011. In the United States, it has been registered since 2010. Structure and properties Eribulin is present in drugs as eribulin mesilate (C40H59NO11 – CH4O3S, Mr = 826.0 g/mol), a white crystalline powder … Eribulin